Covered recipient · General Payments record
JULIA SPOR
General Payments · PY2024
$2,314.06
- Reported across 105 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,305.16 | 104 |
| Education | $8.90 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $519.87 | 12 |
| Novo Nordisk AS | $270.30 | 13 |
| Lilly USA, LLC | $230.55 | 19 |
| Radius Health, Inc. | $177.28 | 11 |
| Tandem Diabetes Care, Inc. | $113.28 | 1 |
| SANOFI-AVENTIS U.S. LLC | $111.09 | 6 |
| Amgen Inc. | $87.42 | 5 |
| CeQur Corporation | $85.61 | 1 |
| Corcept Therapeutics | $61.44 | 3 |
| Endo USA, Inc. | $55.77 | 3 |
| ABBVIE INC. | $54.76 | 3 |
| DEXCOM, INC. | $52.85 | 3 |
| Ascensia Diabetes Care US Inc. | $50.10 | 2 |
| Antares Pharma, Inc. | $48.88 | 2 |
| Alexion Pharmaceuticals, Inc. | $48.09 | 2 |
| RECORDATI_RARE_DISEASES_INC. | $41.88 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $39.99 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.72 | 2 |
| Esperion Therapeutics, Inc. | $32.32 | 2 |
| Phadia US Inc. | $32.31 | 2 |
| Amneal Pharmaceuticals LLC | $31.54 | 2 |
| Insulet Corporation | $22.96 | 1 |
| Kyowa Kirin, Inc. | $22.82 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $18.78 | 1 |
| MannKind Corporation | $18.62 | 1 |
| Currax Pharmaceuticals LLC | $17.86 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.66 | 1 |
| VIVUS LLC | $16.31 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $2,314.06 | 105 |
Payment records · PY2024 (105)
Sorted by paying entity, then date · as published by CMS
Program year 2024
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.